RANKL-stimulated TNFα production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways

Biochemical and Biophysical Research Communications

Volumn 357, Issue 4, 2007, Pages 945-950

  Nakao, Akihiro ^a   Fukushima, Hidefumi ^a   Kajiya, Hiroshi ^a   Ozeki, Satoru ^a   Okabe, Koji ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

c Fos; NFATc1; Osteoclastogenesis; RANKL; TNF

Indexed keywords

OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NFAT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C FOS; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SPLEEN; STEM CELL; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED C57BL; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247880174     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.058     Document Type: Article

References (20)

1. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 (2000) 1504-1508
2. Goldring S.R., and Gravallese E.M. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis. Res. 2 (2000) 33-37
3. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
4. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
5. Merkel K.D., Erdmann J.M., McHugh K.P., Abu-Amer Y., Ross F.P., and Teitelbaum S.L. Tumor necrosis factor-α mediates orthopedic implant osteolysis. Am. J. Pathol. 154 (1999) 203-210
6. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., and Avioli L.V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA 88 (1991) 5134-5138
7. Assuma R., Oates T., Cochran D., Amar S., and Graves D.T. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J. Immunol. 160 (1998) 403-409
8. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., Nakagawa N., Kinosaki M., Yamaguchi K., Shima N., Yasuda H., Morinaga T., Higashio K., Martin T.J., and Suda T. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J. Exp. Med. 191 (2000) 275-286
9. Azuma Y., Kaji K., Katogi R., Takeshita S., and Kudo A. Tumor necrosis factor-α induces differentiation of and bone resorption by osteoclasts. J. Biol. Chem. 275 (2000) 4858-4864
10. Lam J., Takeshita S., Barker J.E., Kanagawa O., Ross F.P., and Teitelbaum S.L. TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J. Clin. Invest. 106 (2000) 1481-1488
11. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., Morita I., Wagner E.F., Mak T.W., Serfling E., and Takayanagi H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202 (2005) 1261-1269
12. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., and Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3 (2002) 889-901
13. Zhang Y.H., Heulsmann A., Tondravi M.M., Mukherjee A., and Abu-Amer Y. Tumor necrosis factor-α (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J. Biol. Chem. 276 (2001) 563-568
14. Zou W., Hakim I., Tschoep K., Endres S., and Bar-Shavit Z. Tumor necrosis factor-α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J. Cell. Biochem. 83 (2001) 70-83
15. Li J., Sarosi I., Yan X.Q., Morony S., Capparelli C., Tan H.L., McCabe S., Elliott R., Scully S., Van G., Kaufman S., Juan S.C., Sun Y., Tarpley J., Martin L., Christensen K., McCabe J., Kostenuik P., Hsu H., Fletcher F., Dunstan C.R., Lacey D.L., and Boyle W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. USA 97 (2000) 1566-1571
16. Bolon B., Campagnuolo G., and Feige U. Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. Cell. Mol. Life Sci. 59 (2002) 1569-1576
17. Nakashima T., Wada T., and Penninger J.M. RANKL and RANK as novel therapeutic targets for arthritis. Curr. Opin. Rheumatol. 15 (2003) 280-287
18. Zou W., Amcheslavsky A., Takeshita S., Drissi H., and Bar-Shavit Z. TNFα expression is transcriptionally regulated by RANK ligand. J. Cell. Physiol. 202 (2005) 371-378
19. Vandenabeele P., Declercq W., Beyaert R., and Fiers W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol. 5 (1995) 392-399
20. Mochizuki A., Takami M., Kawawa T., Suzumoto R., Sasaki T., Shiba A., Tsukasaki H., Zhao B., Yasuhara R., Suzawa T., Miyamoto Y., Choi Y., and Kamijo R. Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand. J. Immunol. 177 (2006) 4360-4368